News

LGC’s leadership confirms that trading is in line with expectations, with positive momentum expected to continue through the second half of the year to 31 March 2025.

LGC acquires DiaMex to drive innovation and choice for core laboratory customers: Acquisition complements LGC’s serology and molecular quality control portfolio and enhances choice of products from a single supplier

LGC Biosearch Technologies launches Amp-Seq One: A revolutionary one-step targeted genotyping by sequencing workflow delivering speed and precision to enhance genomics in commercial breeding. Set to become the fastest amplicon sequencing protocol on the market, Amp-Seq One offers reduced hands-on time and doubled throughput for customers.

Holland & Barrett has inserted their mark on Informed Sport history, as they now hold the record as the company to certify the most products at the beginning of a partnership. With more than 60 product variances through their new and improved range of Precision Engineered Sports nutrition, Holland & Barrett has also become one of the largest ranges in the UK to be certified by Informed Sports.

LGC, a global leader in clinical diagnostics and genomics, announces a new strategic partnership with AccuGenomics, a pioneer in molecular diagnostic development. This collaboration is set to drive innovation in clinical diagnostic tools by combining LGC’s expertise in quality control solutions with AccuGenomics’ advanced next- generation sequencing (NGS) monitoring technologies.

LGC Clinical Diagnostics, a leader in quality solutions for molecular diagnostics, is delighted to announce the launch of the Seraseq® DPYD DNA Mutation Mix. This launch marks LGC Clinical Diagnostics’ entry into the rapidly expanding field of pharmacogenomics, furthering its commitment to personalized medicine. This cutting-edge reference material is designed for developing, validating, and routinely evaluating Next Generation Sequencing (NGS) assays and other molecular assays that detect critical mutations in the DPYD gene.

Melbourne, 19 September 2024 -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of genomics in agricultural applications.

LGC appoints Dr Alexander Zahiri as Executive Vice President & General Manager, Axolabs

LGC appoints Marcus Kaeller as Chief Financial Officer

Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project

The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing.

LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes